000 | 01373 a2200361 4500 | ||
---|---|---|---|
005 | 20250515050444.0 | ||
264 | 0 | _c20070228 | |
008 | 200702s 0 0 ger d | ||
022 | _a0040-5930 | ||
024 | 7 |
_a10.1024/0040-5930.63.12.777 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaefeli, W E | |
245 | 0 | 0 |
_a[Individualising the evidence--single case randomized trial]. _h[electronic resource] |
260 |
_bTherapeutische Umschau. Revue therapeutique _cDec 2006 |
||
300 |
_a777-81 p. _bdigital |
||
500 | _aPublication Type: Case Reports; English Abstract; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xadverse effects |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 | _aBlood Pressure Monitoring, Ambulatory |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aErectile Dysfunction _xdrug therapy |
650 | 0 | 4 | _aEvidence-Based Medicine |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNifedipine _xtherapeutic use |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aYohimbine _xadverse effects |
773 | 0 |
_tTherapeutische Umschau. Revue therapeutique _gvol. 63 _gno. 12 _gp. 777-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1024/0040-5930.63.12.777 _zAvailable from publisher's website |
999 |
_c16703812 _d16703812 |